Clever Leaves Holdings Inc. (CLVR) vs Sofgen Pharma S.A (PROCF)

Clever Leaves Holdings Inc. and Sofgen Pharma S.A are both Drug Manufacturers Specialty & Generic companies. Sofgen Pharma S.A is the larger, with a market value of $114.0M against $96.5M — 1.2× the size. Clever Leaves Holdings Inc. grew revenue faster over the last twelve months: 6.14% against 5.10%. Sofgen Pharma S.A has the higher net margin (9.52% vs −102.8%) and the higher return on invested capital (15.2% vs −52.6%). Across the 14 metrics below, Sofgen Pharma S.A leads on 8 and Clever Leaves Holdings Inc. on 6.

Valuation

Metric CLVR PROCF Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.14
P/S n/m n/m 2.25
P/B n/m n/m 1.90
Price to free cash flow n/m n/m 16.54
EV/EBITDA 0.45 3.29 12.29
EV/Sales (0.33) 0.70 2.56
Earnings yield 0.00% 0.00% (2.99%)
Free cash flow yield 0.00% 0.00% 0.00%

Profitability

Metric CLVR PROCF Drug Manufacturers Specialty & Generic median
Gross margin 37.64% 56.16% 53.94%
Operating margin (89.53%) 17.01% 0.00%
Net margin (102.77%) 9.52% 0.00%
Free cash flow margin (49.82%) 17.66% 0.00%
Return on equity (55.39%) (213.06%) (0.40%)
Return on assets (42.95%) 8.82% (3.32%)
Return on invested capital (52.59%) 15.21% 0.00%

Growth

Metric CLVR PROCF Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 6.14% 5.10% 10.01%
EPS growth (last fiscal year) 77.89% (270.30%) —
Revenue growth, 5-year CAGR — (1.82%) 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CLVR PROCF Drug Manufacturers Specialty & Generic median
Debt to equity 0.05 (435.78) 0.05
Current ratio 2.40 0.64 2.31
Net debt to EBITDA 0.45 (7.21) 0.85

Dividend

Metric CLVR PROCF Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric CLVR PROCF Drug Manufacturers Specialty & Generic median
Market cap 96.49m 113.95m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack